Kenvue Inc.
KVUE- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- SEC CIK
- 0001944048
No open-market purchases or sales by Kenvue Inc. insiders were filed in the last 90 days; 1,020 institutions reported holding it in 13F filings for Q2 2026, worth $34.6B in total; 3 superinvestors hold it, including Starboard Value and Soros Fund Management.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 31, 2026, 1:14 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 |
| Filing | 10-K | 10-K | 10-K |
| Reported | Feb 17, 2026 | Feb 6, 2025 | Feb 8, 2024 |
| Revenue | $15.1B | $15.5B | $15.4B |
| Cost of revenue | $6.33B | $6.50B | $6.80B |
| Gross profit | $8.79B | $8.96B | $8.64B |
| Research and development | $382.0M | $408.0M | $399.0M |
| Selling, general and administrative | $6.09B | $6.33B | $6.14B |
| Operating income | $2.41B | $1.84B | $2.51B |
| Interest expense | $430.0M | $431.0M | $250.0M |
| Income tax | $529.0M | $385.0M | $526.0M |
| Net income | $1.47B | $1.03B | $1.66B |
| EPS, basic | $0.77 | $0.54 | $0.90 |
| EPS, diluted | $0.76 | $0.54 | $0.90 |
| Weighted shares, basic | 1.92B | 1.92B | 1.85B |
| Weighted shares, diluted | 1.92B | 1.92B | 1.85B |
| Margins and growth | |||
| Gross margin | 58.1% | 58.0% | 56.0% |
| Operating margin | 16.0% | 11.9% | 16.3% |
| Net margin | 9.7% | 6.7% | 10.8% |
| Revenue growth, year over year | −2.1% | +0.1% | – |
| Net income growth, year over year | +42.7% | −38.1% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 |
| Filing | 10-K | 10-K | 10-K |
| Reported | Feb 17, 2026 | Feb 6, 2025 | Feb 8, 2024 |
| Cash and equivalents | $1.06B | $1.07B | $1.38B |
| Accounts receivable | $2.38B | $2.17B | $2.07B |
| Inventory | $1.67B | $1.59B | $1.85B |
| Total current assets | $5.70B | $5.53B | $6.14B |
| Property, plant and equipment | $2.21B | $1.85B | $2.04B |
| Goodwill | $9.51B | $8.84B | $9.27B |
| Intangible assets | $8.69B | $8.47B | $9.62B |
| Total assets | $27.1B | $25.6B | $27.9B |
| Accounts payable | $2.47B | $2.25B | $2.49B |
| Short-term debt | $1.45B | $1.55B | $599.0M |
| Total current liabilities | $5.95B | $5.74B | $5.48B |
| Long-term debt | – | – | $7.69B |
| Total liabilities | $16.3B | $15.9B | $16.6B |
| Shareholders' equity | $10.8B | $9.67B | $11.2B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 |
| Filing | 10-K | 10-K | 10-K |
| Reported | Feb 17, 2026 | Feb 6, 2025 | Feb 8, 2024 |
| Operating cash flow | $2.20B | $1.77B | $3.17B |
| Capital expenditures | $475.0M | $434.0M | $469.0M |
| Free cash flow | $1.72B | $1.33B | $2.70B |
| Depreciation and amortization | $557.0M | $622.0M | $627.0M |
| Stock-based compensation | $136.0M | $254.0M | $188.0M |
| Dividends paid | $1.58B | $1.55B | $766.0M |
| Share buybacks | $197.0M | $235.0M | – |
| Investing cash flow | -$436.0M | -$425.0M | -$488.0M |
| Financing cash flow | -$1.84B | -$1.56B | -$2.53B |
| Net change in cash | -$8.00M | -$312.0M | $151.0M |
| Ratio | |||
| Stock-based compensation, % of revenue | 0.9% | 1.6% | 1.2% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.